AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2

Vildawalf-M Tablet

Prescription Icon
Prescription Required

Marketer

Walfs Pharma Pvt Ltd

Salt Composition

Metformin (500mg) + Vildagliptin (50mg)

Overview Vildawalf-M Tablet

Diabex Duo tablets combine two medications to effectively manage elevated blood glucose in patients with type 2 diabetes. This dual action helps prevent severe diabetic complications like vision impairment and kidney disease, and may lessen the risk of cardiovascular events such as stroke or heart attack. Diabex Duo may be used independently or in conjunction with other antidiabetic therapies. Optimal results require adherence to a healthy lifestyle encompassing proper diet and regular physical activity. Dosage is personalized based on individual health status, blood glucose readings, and concurrent medications. Consuming the tablets with food minimizes gastrointestinal discomfort. Consistent daily dosing at the same time maximizes therapeutic benefits; discontinuation should only occur under physician guidance. Maintaining controlled blood sugar levels mitigates the risk of future complications. Continued adherence to your doctor's dietary and exercise plan is crucial for successful diabetes management; lifestyle significantly influences disease control. Commonly reported side effects include nausea, vomiting, diarrhea, stomach upset, headache, pharyngitis, fatigue, GERD, hyperhidrosis, and anorexia. Hypoglycemia is a potential adverse effect, particularly when used with insulin or sulfonylureas; patients should learn to identify and manage this condition. This medication is not universally suitable. Prior to commencing treatment, inform your physician of any pre-existing heart, liver, kidney, or pancreatic conditions, excessive alcohol consumption, or pregnancy/breastfeeding. Disclosure of all medications is necessary to ensure treatment safety as drug interactions can occur. Alcohol should be avoided due to its hypoglycemic effects. Your doctor will monitor kidney function and blood glucose levels throughout the course of therapy.

Primary Ingredients of Vildawalf-M Tablet

No text provided to rephrase.

Uses of Vildawalf-M Tablet

Managing type 2 diabetes

Major Benefits of Vildawalf-M Tablet:

Consume this medication precisely as your physician directs, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It's recommended to take Vildawalf-M Tablet with a meal.

Common Side effects of Vildawalf-M Tablet:

  • Hypoglycemia (low blood glucose level)
  • Trembling
  • Headache
  • Dizziness
  • Nausea
  • Weakness
  • Gastro-esophageal reflux disease
  • Increased sweating
  • Decreased appetite

How to use Vildawalf-M Tablet:

Consume this medication according to your physician's prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Vildawalf-M Tablet with food.

How Vildawalf-M Tablet works:

Vildawalf-M tablets contain a dual-action formulation of antidiabetic medications.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Vildawalf-M Tablet and alcohol is inadvisable due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Vildawalf-M Tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible dangers prior to prescription. Physician consultation is advised.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Vildawalf-M Tablet while breastfeeding is likely inadvisable. Scant evidence in humans indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

Patients with kidney impairment should exercise caution when using Vildawalf-M tablets, as dosage modification may be necessary. Physician consultation is recommended.

LiverLiverUNSAFE

Patients with liver conditions should not take Vildawalf-M Tablets; its use is potentially hazardous in such cases. Seek medical advice.

What if you forget to take Vildawalf-M Tablet :

Should you forget a Vildawalf-M Tablet dose, take it immediately. Nevertheless, if your next dose is imminent, omit the missed one and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Vildawalf-M Tablet

LabelValue
Developing Habits No.
Type of Therapy Diabetes Management

FAQs on Vildawalf-M Tablet

Vildawalf-M Tablets rarely cause hypoglycemia by themselves, but low blood sugar can result from inadequate caloric intake while using the medication. Symptoms include nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, and anxiety or shakiness. These are more likely if meals are missed or delayed, alcohol is consumed, excessive exercise occurs, or other antidiabetic medications are taken concurrently. Therefore, regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Nausea and vomiting are possible side effects of Vildawalf-M Tablets. If vomiting occurs, sip small amounts of water or other fluids frequently. Consult your doctor if vomiting continues or you experience dehydration symptoms such as dark, strong-smelling urine and infrequent urination. Do not take other medications without your doctor's advice.
Vildawalf-M Tablets are contraindicated in patients allergic to any constituent or excipient. This medication should also not be used by those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Vildawalf-M Tablet combines the anti-diabetic medications metformin (a biguanide) and vildagliptin. Metformin reduces liver glucose production, slows intestinal glucose absorption, and enhances insulin sensitivity. Vildagliptin, a DPP-4 inhibitor, boosts insulin release from the pancreas. This combination is contraindicated for individuals under 18.
Vildawalf-M Tablet use can cause lactic acidosis, a serious medical emergency involving high blood lactic acid levels (also known as MALA, or Metformin-associated lactic acidosis). This rare side effect necessitates caution in patients with kidney disease, older adults, or those consuming excessive alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If these occur, discontinue Vildawalf-M Tablet and seek immediate medical attention.
Prolonged Vildawalf-M Tablet use can lead to vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency, if left untreated, may result in anemia and neurological complications.
Vildawalf-M Tablet is safe when used as directed by your doctor. However, even with proper dosage, you may experience side effects such as nausea, diarrhea, vomiting, stomach upset, headache, nasal congestion, sore throat, respiratory infection, or low blood sugar (hypoglycemia, especially if you also take insulin or sulphonylurea). Report any persistent side effects to your physician.
Vildawalf-M Tablet
78
MRP 90
13% off